Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bio Unloads Part of Its Capital Equipment Biz for $1M, Plus Earn-out

NEW YORK (GenomeWeb News) - Harvard Bioscience said yesterday that it has sold its Genomics Solutions division and Maia Scientific business to Digilab for $1 million in cash and a 20 percent earn-out of the revenue the businesses generate over a three-year, post-transaction period.
Both businesses were part of the company’s Capital Equipment Business Segment, which Harvard Bio has been trying to sell for more than two years.
Harvard Bio will hold the rights to certain deferred tax assets, which the company said are currently offset by valuation allowances.
The firm said it still is looking to sell its COPAS flow cytometry products, which are held under its Union Biometrica US and German subsidiaries and were not a part of the Digilab deal.
Harvard Bio President David Green said the divestiture of the capital equipment division will allow the firm to “focus our resources on our apparatus and instrumentation business and to continue our pursuit of tuck-under acquisitions.”

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.